These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 32067555

  • 1. Pharmacist Interventions in the Management of Blood Pressure Control and Adherence to Antihypertensive Medications: A Systematic Review of Randomized Controlled Trials.
    Reeves L, Robinson K, McClelland T, Adedoyin CA, Broeseker A, Adunlin G.
    J Pharm Pract; 2021 Jun; 34(3):480-492. PubMed ID: 32067555
    [Abstract] [Full Text] [Related]

  • 2. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta-analysis.
    Jia X, Zhou S, Luo D, Zhao X, Zhou Y, Cui YM.
    J Clin Pharm Ther; 2020 Oct; 45(5):904-917. PubMed ID: 32107837
    [Abstract] [Full Text] [Related]

  • 3. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.
    Morgado M, Rolo S, Castelo-Branco M.
    Int J Clin Pharm; 2011 Feb; 33(1):132-40. PubMed ID: 21365405
    [Abstract] [Full Text] [Related]

  • 4. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
    Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L.
    Cochrane Database Syst Rev; 2010 Jul 07; 2010(7):CD000336. PubMed ID: 20614422
    [Abstract] [Full Text] [Related]

  • 5. Community pharmacist-led interventions to improve medication adherence in patients with cardiovascular disease: a systematic review of randomised controlled trials.
    Al-Arkee S, Al-Ani O.
    Int J Pharm Pract; 2023 May 07; 31(3):269-275. PubMed ID: 36821553
    [Abstract] [Full Text] [Related]

  • 6. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.
    Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, Burnand B, Paradis G.
    J Am Heart Assoc; 2014 Apr 10; 3(2):e000718. PubMed ID: 24721801
    [Abstract] [Full Text] [Related]

  • 7. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis.
    Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M.
    Am J Health Syst Pharm; 2011 Feb 01; 68(3):241-53. PubMed ID: 21258029
    [Abstract] [Full Text] [Related]

  • 8. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
    Pousinho S, Morgado M, Falcão A, Alves G.
    J Manag Care Spec Pharm; 2016 May 01; 22(5):493-515. PubMed ID: 27123912
    [Abstract] [Full Text] [Related]

  • 9. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: A systematic review and meta-analysis.
    Readdean KC, Heuer AJ, Scott Parrott J.
    Res Social Adm Pharm; 2018 Apr 01; 14(4):321-331. PubMed ID: 28622997
    [Abstract] [Full Text] [Related]

  • 10. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review.
    El Hajj MS, Jaam MJ, Awaisu A.
    Res Social Adm Pharm; 2018 Jun 01; 14(6):507-520. PubMed ID: 28641999
    [Abstract] [Full Text] [Related]

  • 11. Managing Medication Adherence in Elderly Hypertensive Patients Through Pharmacist Home Visits.
    Moultry AM, Pounds K, Poon IO.
    Consult Pharm; 2015 Dec 01; 30(12):710-9. PubMed ID: 26671271
    [Abstract] [Full Text] [Related]

  • 12. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM, Elders PJ, Boons CC, Bosmans JE, Nijpels G, Hugtenburg JG.
    Trials; 2017 Jan 19; 18(1):29. PubMed ID: 28103948
    [Abstract] [Full Text] [Related]

  • 13. Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists.
    Beran M, Asche SE, Bergdall AR, Crabtree B, Green BB, Groen SE, Klotzle KJ, Michels RD, Nyboer RA, O'Connor PJ, Pawloski PA, Rehrauer DJ, Sperl-Hillen JM, Trower NK, Margolis KL.
    J Am Pharm Assoc (2003); 2018 Jan 19; 58(6):614-621. PubMed ID: 30077564
    [Abstract] [Full Text] [Related]

  • 14. A systematic review investigating the role and impact of pharmacist interventions in cardiac rehabilitation.
    Ahmed A, Guo P, Jalal Z.
    Int J Clin Pharm; 2023 Apr 19; 45(2):320-329. PubMed ID: 36401764
    [Abstract] [Full Text] [Related]

  • 15. Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: A meta-analysis of randomized clinical trials.
    Nakanishi M, Mizuno T, Mizokami F, Koseki T, Takahashi K, Tsuboi N, Katz M, Lee JK, Yamada S.
    J Clin Pharm Ther; 2021 Feb 19; 46(1):114-120. PubMed ID: 32949161
    [Abstract] [Full Text] [Related]

  • 16. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.
    Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, Singh RF, Wood Y, Kaplan RM, Mangione CM.
    Clin Ther; 2014 Sep 01; 36(9):1244-54. PubMed ID: 25085406
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ, Buffington DE, Carter BL, Smith M, Polgreen LA, James PA.
    Pharmacotherapy; 2016 Apr 01; 36(4):374-84. PubMed ID: 26893135
    [Abstract] [Full Text] [Related]

  • 18. Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials.
    Al-Babtain B, Cheema E, Hadi MA.
    Res Social Adm Pharm; 2022 Apr 01; 18(4):2559-2568. PubMed ID: 33965357
    [Abstract] [Full Text] [Related]

  • 19. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, Chung N, Fleming M.
    J Manag Care Spec Pharm; 2016 Jan 01; 22(1):63-73. PubMed ID: 27015053
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of community pharmacist-provided telephone interventions to improve adherence to hypertension and diabetes medications.
    Stanton-Robinson C, Al-Jumaili AA, Jackson A, Catney C, Veach S, Witry MJ.
    J Am Pharm Assoc (2003); 2018 Jan 01; 58(4S):S120-S124. PubMed ID: 29891173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.